Establishment of the first WHO International Standard for etanercept, a TNF receptor II Fc fusion protein: Report of an international collaborative study-Reference-Cited by-同舟云学术

Establishment of the first WHO International Standard for etanercept, a TNF receptor II Fc fusion protein: Report of an international collaborative study

Published:2017-08 Issue: Volume:447 Page:14-22
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Wadhwa Meenu,Bird Chris,Dilger Paula,Rigsby Peter,Jia Haiyan,Gross Marie Emmanuelle Behr

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference15 articles.

1. Differences in binding and effector functions between classes of TNF antagonists;Arora;Cytokine,2009

2. Etanercept biosimilars;Azevedo;Rheumatol. Int.,2015

3. TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells;Butler;Cytokine,1994

4. Etanercept: an overview;Goffe;J. Am. Acad. Dermatol.,2003

5. Predicting the stability of biological standards and products;Kirkwood;Biometrics,1977

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of World Health Organization international reference standards in the product life cycle of biosimilars;Annals of the New York Academy of Sciences;2024-09-10

2. International standards for monoclonal antibodies for assessing the biological activity of medicines: A status update;Biological Products. Prevention, Diagnosis, Treatment;2023-12-17

3. The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab;Biomolecules;2021-10-30

4. Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19;Biomedicine & Pharmacotherapy;2021-08

5. The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring;Frontiers in Immunology;2021-04-15